From ESC: Statin Nonadherence, LDL Cholesterol Lowering After Acute MI, Ablation Therapy for Atrial Fibrillation, Advances in Cardiac Amyloidosis, and more
Summary
This JAMA Editors’ Summary podcast reviews key cardiology research from the European Society of Cardiology Congress. Hosts discuss trials on early PCSK9 inhibitor use, digital statin adherence interventions, and ICD implantation guided by cardiac MRI. Additional topics include atrial fibrillation ablation strategies, AI-driven screening for aortic stenosis and cardiac amyloidosis, and new classifications for myocardial infarction.
Topics discussed
Introduction to Healthy Dialog and ESC Congress overview
Evolocumab as first-line therapy after acute MI (AMUNDSEN trial)
Digital outreach interventions to improve statin adherence
Cardiac MRI-guided ICD implantation (CMR-GUIDE trial)
Ablation therapy for atrial fibrillation: Posterior wall vs low voltage
AI-enabled ECG screening for transthyretin amyloid cardiomyopathy
New imaging agents and combination therapies for cardiac amyloidosis
Anticoagulation vs antiplatelet therapy after TAVR
Machine learning risk prediction models in ATTR cardiomyopathy
Prognostic value of tricuspid regurgitation in ATTR cardiomyopathy
AI-enabled community screening for aortic stenosis
Causal endotype classification of myocardial infarction and conclusion
Listen ad-free on Castria